Maxalt

Type: Product
Name: Maxalt
First reported Aug 23 2014 - Updated Aug 23 2014 - 1 reports

Managing Migraines: Three Experts Share Their Top Tips

The debilitating effects of migraines can last anywhere from an hour to several days. The headaches are characterized by severe pain and often preceded by an aura—flashes of light, blind spots and nausea.Doctors frequently prescribe drugs such as calcium ... [Published Reader's Digest Canada - Aug 23 2014]
Entities: Megrim, Zomig, Maxalt, Imitrex
First reported Aug 22 2014 - Updated Aug 22 2014 - 1 reports

Vets Fight Against Prescription Drugs and Prescribing Doctors

Veterans returning from Iraq and Afghanistan are fighting a new battle on the home front against prescription drug addiction, as many VA doctors seem all-too-willing to prescribe away their pain and struggles.On average, servicemen and women are prescribed ... [Published Fix.com - Aug 22 2014]
First reported Aug 07 2014 - Updated Aug 07 2014 - 1 reports

IntelGenx Reports Q2, 2014 Results and Provides Corporate Development Update

SAINT LAURENT, Quebec, Aug. 7, 2014 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSX-V:IGX) (OTCQX:IGXT) ("IntelGenx") today announced financial results for the three and six months ended June 30, 2014 and provided an update on corporate developments. All amounts ... [Published Benzinga.com - Aug 07 2014]
First reported Aug 06 2014 - Updated Aug 06 2014 - 1 reports

UCB hops on pharma's spinoff wagon with potential $2B sale of generics business

Shedding non-core assets is the trend du jour in Big Pharma, and now another company may be jumping on the bandwagon. Belgium's UCB is reportedly looking into a sale of Kremers Urban Pharmaceuticals, its Princeton, NJ-based generics unit.The business ... [Published FiercePharma - Aug 06 2014]
First reported May 14 2014 - Updated May 14 2014 - 1 reports

Research and Markets: Global RHB-103 (Migraine) Forecast and Market Analysis to 2023

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/3pv8pm/rhb103) has announced the addition of the "RHB-103 (Migraine) - Forecast and Market Analysis to 2023" report to their offering. RedHill Biopharma (RedHill) ... [Published Business Wire Health News - May 14 2014]
First reported May 13 2014 - Updated May 13 2014 - 1 reports

MAXALT-MLT (Rizatriptan Benzoate) Tablet, Orally Disintegrating [Frosst Iberica, S.A.]

Entities: Maxalt
First reported Apr 30 2014 - Updated Apr 30 2014 - 1 reports

RedHill, IntelGenx begin bioavailability study with RHB-103

RedHill Biopharma, an emerging Israeli biopharmaceutical company focused primarily on the development and acquisition of late clinical-stage proprietary drugs, together with IntelGenx Corp, a Canadian drug delivery company focused on oral drug delivery, ... [Published PharmaBiz - Apr 30 2014]
First reported Mar 25 2014 - Updated Mar 25 2014 - 1 reports

Basilar migraines

Hi, I had my very first migraine earlier this month. Thankfully, it’s pretty much gone, but it lasted about three weeks, with the first ten days being the absolute worst! I’m seeing my neurologist tomorrow, and I’m thinking about talking to her about ... [Published HealthBoards - Mar 25 2014]
Entities: Megrim, Maxalt, Imitrex
First reported Mar 22 2014 - Updated Mar 22 2014 - 1 reports

RIZATRIPTAN Tablet, Film Coated [Macleods Pharmaceuticals Limited]

Entities: Maxalt, Pharmaceutical
First reported Mar 18 2014 - Updated Mar 19 2014 - 1 reports

RIZATRIPTAN Tablet, Film Coated [Macleods Pharmaceuticals Limited]

Entities: Maxalt, Pharmaceutical

Quotes

"They're using psych drugs off label—way, way, way off label," he said. "Obviously, they are not using them to treat the major disorders for which these drugs are designed…They were in a different situation, where they had unprecedented levels of stress in a group of otherwise healthy people…I think they resorted to psychopharmacology as a means to keep people in active duty."

More Content

All (14) | News (7) | Reports (0) | Blogs (5) | Audio/Video (0) | Fact Sheets (0) | Press Releases (2)
sort by: Date | Relevance
Managing Migraines: Three Experts Share Their T... [Published Reader's Digest Canada - Aug 23 2014]
Vets Fight Against Prescription Drugs and Presc... [Published Fix.com - Aug 22 2014]
IntelGenx Reports Q2, 2014 Results and Provides... [Published Benzinga.com - Aug 07 2014]
UCB hops on pharma's spinoff wagon with potenti... [Published FiercePharma - Aug 06 2014]
RedHill Biopharma and IntelGenx Report Positive... [Published GlobeNewswire: Acquisitions News - May 21 2014]
IntelGenx and RedHill Biopharma Report Positive... [Published GlobeNewswire: Acquisitions News - May 21 2014]
Research and Markets: Global RHB-103 (Migraine)... [Published Business Wire Health News - May 14 2014]
MAXALT-MLT (Rizatriptan Benzoate) Tablet, Orall... [Published DailyMed Drug Label Updates for the last seven ... - May 13 2014]
RedHill, IntelGenx begin bioavailability study ... [Published PharmaBiz - Apr 30 2014]
Basilar migraines [Published HealthBoards - Mar 25 2014]
RIZATRIPTAN Tablet, Film Coated [Macleods Pharm... [Published DailyMed Drug Label Updates for the last seven ... - Mar 22 2014]
RIZATRIPTAN Tablet, Film Coated [Macleods Pharm... [Published DailyMed Drug Label Updates for the last seven ... - Mar 18 2014]
RedHill Biopharma receives complete response le... [Published Pharmaceutical Business Review - Feb 05 2014]
Fake Headache Treatment May Be As Good As the R... [Published ThirdAge - Jan 10 2014]
1
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Research and Markets: Global RHB-103 (Migraine)... [Published Business Wire Health News - May 14 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/3pv8pm/rhb103) has announced the addition of the "RHB-103 (Migraine) - Forecast and Market Analysis to 2023" report to their offering. RedHill Biopharma (RedHill) ...
MAXALT-MLT (Rizatriptan Benzoate) Tablet, Orall... [Published DailyMed Drug Label Updates for the last seven ... - May 13 2014]
Updated Date: May 13, 2014 EST ...
Basilar migraines [Published HealthBoards - Mar 25 2014]
Hi, I had my very first migraine earlier this month. Thankfully, it’s pretty much gone, but it lasted about three weeks, with the first ten days being the absolute worst! I’m seeing my neurologist tomorrow, and I’m thinking about talking to her about ...
RIZATRIPTAN Tablet, Film Coated [Macleods Pharm... [Published DailyMed Drug Label Updates for the last seven ... - Mar 22 2014]
Updated Date: Mar 18, 2014 EST ...
RIZATRIPTAN Tablet, Film Coated [Macleods Pharm... [Published DailyMed Drug Label Updates for the last seven ... - Mar 18 2014]
Updated Date: Mar 18, 2014 EST ...
1

Press Releases

sort by: Date | Relevance
RedHill Biopharma and IntelGenx Report Positive... [Published GlobeNewswire: Acquisitions News - May 21 2014]
IntelGenx and RedHill Biopharma Report Positive... [Published GlobeNewswire: Acquisitions News - May 21 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.